An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results.

The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49%, a new study ...

The Food and Drug Administration (FDA) has withdrawn studies that suggested COVID-19 and shingles vaccines were safe and ...

The Food and Drug Administration (FDA) in recent months stopped publication of studies about the safety of COVID-19 and shingles vaccines, a spokesperson for the Department of Health and Human ...

Right now, there are so many questions about COVID-19 vaccines: Who should get them, will insurance cover the cost, where can a person get vaccinated? With all the confusion, some may wonder if they ...

Vanderbilt University Medical Center's vaccine center has the antibodies to make a hantavirus vaccine. But to get it into development, it needs $25 to $50 million. Here's why it hasn't been made, what ...

Vaccination rates for Oregon students hit a new low this school year, while non-medical vaccine exemptions have reached a new ...